Drinking on semaglutide and drinking on tirzepatide is possible but comes with metabolic consequences that directly affect weight loss progress
First, side effects are clearly dose-dependent, increasing as the dose goes up
Levels of triglycerides, another lipid linked to heart disease, dropped 37% in the bean-eating mice
You'll see it listed as GHK-Cu, copper peptide GHK, or Copper Tripeptide-1 depending on the brand
But they are approved only for diabetes and weight-loss so far
Studies are also underway to assess the efficacy of GLP1s for: Addiction: Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity (Scientific Reports, Nature), Semaglutide for Alcohol Use Disorder (Phase II clinical trial by UNC) Alzheimer's: The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease (Frontiers in Endocrinology) Mental Health & Suicidal Ideation: Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Depression Diagnoses (Epic Research) Alcohol-related liver disease ( Novo Nordisk clinical trial ) Osteoarthritis ( STEP 9 ) Metabolic dysfunction-associated steatohepatitis (MASH): Tirzepatide for Metabolic DysfunctionAssociated Steatohepatitis with Liver Fibrosis This is just the beginning
